Clinical Trial of Ublituximab and Umbralisib With CHOP (U2-CHOP) Followed by U2 Maintenance (U2-CHOP-U2) in Previously Untreated Mantle Cell Lymphoma (MCL)
Clinical trial NCT04692155 · TERMINATED
Trial details
- NCT number
- NCT04692155
- Sponsor
- University of Alabama at Birmingham
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-31
- Primary completion
- 2022-06-30
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.